Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Autoyos is an Indian private healthtech and medical-device company focused on ophthalmology and decentralized eye care. The company develops AI-enabled autonomous diagnostic systems and digital tools intended to deliver eye-care services in non-clinical or resource-constrained settings with minimal operator dependence. Its disclosed products include iDEA, an AI-enabled multispectral imaging diagnostic system, and EyeD, a mobile application for dry eye disease management and screening support. Public profiles also describe the company as applying eye-image analysis to detect ocular abnormalities and potentially broader systemic conditions through retinal or eye-based imaging workflows. The business appears to be an early-stage, venture-backed company founded in 2019 and headquartered in Bengaluru, India.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Autoyos.